Antithrombotic Drug Therapy in Cardiovascular Disease

Antithrombotic Drug Therapy in Cardiovascular Disease pdf epub mobi txt 电子书 下载 2025

出版者:
作者:Askari, Arman T., M.D. (EDT)/ Lincoff, A. Michael, M.D. (EDT)
出品人:
页数:888
译者:
出版时间:2009-12
价格:$ 349.17
装帧:
isbn号码:9781603272346
丛书系列:
图书标签:
  • Antithrombotic Therapy
  • Cardiovascular Disease
  • Thrombosis
  • Anticoagulants
  • Antiplatelet Agents
  • Heart Disease
  • Stroke
  • Vascular Medicine
  • Clinical Pharmacology
  • Guidelines
想要找书就要到 小美书屋
立刻按 ctrl+D收藏本页
你会得到大惊喜!!

具体描述

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, "Antithrombotic Drug Therapy in Cardiovascular Disease" carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, "Antithrombotic Drug Therapy in Cardiovascular Disease" presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

作者简介

目录信息

读后感

评分

评分

评分

评分

评分

用户评价

评分

评分

评分

评分

评分

本站所有内容均为互联网搜索引擎提供的公开搜索信息,本站不存储任何数据与内容,任何内容与数据均与本站无关,如有需要请联系相关搜索引擎包括但不限于百度google,bing,sogou

© 2025 book.quotespace.org All Rights Reserved. 小美书屋 版权所有